|
In clinical trials,
the protection of the subject is
paramount especially when untested
therapy isused. There must also be
assurance about the conduct of clinical
trials in terms of elimination of
cheating, fraud or accidental error.
Problems of poor study design must be
avoided. Adherence to GCP is vital
otherwise, subjects participating in the
trials may be put at risk or the
clinical trial data submitted may be
rejected by health authorities and the
scientific committee, if found to be
unreliable. Also, the research
credibility of the researcher and the
research institution may be damaged.
Malaysia
adopted GCP in
1999, and since
then doctors are
required to
undergo training
on GCP leading
to certification
prior to
participation in
clinical trials.
This course is
specifically
designed to meet
this
requirement.
|